Objective: We investigated whether there was a growth or morbidity response to zinc supplementation. Design: The study was randomized, placebo-controlled, and double-blind. Setting: Children were recruited at clinics in Kingston, Jamaica, and supplemented at home. Subjects: Children selected were singletons aged 6±24 months, and stunted (`À2.0 s.d. length for age, NCHS references). They were strati®ed by sex and age and randomly assigned to receive zinc supplement (n 31) or placebo (n 30). Four children were excluded because of hospitalization; all others had all measurements. Adequately nourished children (n 24) were recruited from a well-baby clinic. Interventions: The supplement provided 5 mg elemental zinc in a syrup daily for 12 weeks; the placebo comprised the syrup only. Main outcome measures: Caretakers were interviewed to obtain social background data, number of clinic visits and hospitalizations. Anthropometric measurements were done on enrolment, and after 6 weeks, 12 weeks and 12 months. Children's health was determined by weekly questionnaire to caretakers of the undernourished groups during the supplementation period. Results: The supplemented and placebo groups were similar on enrolment. The adequately nourished children were from signi®cantly better socio-economic circumstances. Mean initial hair zinc content was 5.5 AE 4.8 mmolag (supplemented group) and 6.7 AE 12.1 mmolag (placebo)(n.s.). Regression analyses showed that there were no signi®cant effects of supplementation on length, height or head circumference, nor on the incidence of any morbidity symptom. Mean duration of the episodes was signi®cantly shorter for skin rashes in the supplemented group compared with the control group (ANCOVA, P 0.02), and longer for vomiting (P 0.02). The incidence of hospitalization was signi®cantly greater in the control group (Fisher's exact test, P 0.02). Conclusions: Zinc supplementation reduced the hospitalizations which probably re¯ect severity of morbidity, but did not improve growth.
Introduction
Zinc de®ciency in young children has been shown to be associated with poor growth and increased morbidity in cross-sectional studies conducted worldwide (Hambridge et al, 1972; Buzina et al, 1980; Chen et al, 1985; SmitVanderkooy & Gibson, 1987; Cavan et al, 1993a) . However, the effect of zinc supplementation on growth is unclear. Several studies have been carried out worldwide and many of these showed a positive effect of zinc supplementation on growth among groups of children who were nutritionally disadvantaged in some way, including stunted children (Walravens & Hambridge, 1976; Walravens et al, 1983 Walravens et al, , 1989 Nakamura et al, 1993) , and in particular among malnourished children (Golden & Golden, 1981; Castillo-Duran et al, 1987; Schlesinger et al, 1992; Shrivastava et al, 1993; Ninh et al, 1996) . However, different anthropometric parameters were affected. A recent meta-analysis of 25 studies also indicated that zinc supplementation had a positive effect on height for age and weight for age, but had no effect on weight for height among different groups of children (Brown, 1996) . On the other hand, there was no growth response to supplementation in stunted Guatemalan children (Cavan et al, 1993b) , possibly because stunting in this population was related to factors other than inadequate zinc; nor was there a growth response to supplementation in a recent Mexican study among stunted preschoolers (Rosado et al, 1997) .
Several studies have also been carried out in which the effects of zinc supplementation on morbidity were examined and it is well documented that zinc de®ciency depresses immune function. Zinc supplementation reduced the incidence (Sazawal et al, 1996) , duration and severity of diarrhoea in children (Sazawal et al, 1995) and had protective effects on diarrhoea and respiratory infections (Black, 1996) .
In this study, we investigated whether young stunted children in Jamaica showed a morbidity or growth response to zinc supplementation. Dietary intake data among chil-dren of the same age range from similar neighborhoods in Jamaica indicated that their diets consisted largely of cereals, dairy products and sugars with small amounts of meat, ®sh, eggs, fruits or vegetables (Walker et al, 1990) . This pattern suggests that the diets may have provided marginal zinc. We studied stunted children because stunting is highly prevalent worldwide and is associated with detrimental outcomes (Waterlow, 1988) . Furthermore, the effect of zinc supplementation among stunted children is particularly inconsistent.
Methods

Subjects
Children were recruited from nutrition clinics in poor, urban areas in Kingston, Jamaica. At these outpatient clinics severely malnourished children who have been treated in hospital, or less severely malnourished children who are not admitted to hospital, are monitored; their caretakers are given feeding advice and food supplements are provided. The ®rst children meeting the selection criteria and whose parents or guardians gave informed consent were enrolled. Children selected were singletons aged 6±24 months, below 72.0 s.d. length for age and less than the median weight for length (Hamill et al, 1977) , and with no obvious physical or mental handicap. Children whose caretakers provided vitamin-mineral supplements which contained iron andaor zinc were excluded. Sixtyone children were identi®ed, who were then strati®ed by sex and age (6±`12, 12±`18, 18±24 months), and randomly assigned to receive zinc supplementation (n 31) or the placebo (n 30). A comparison group of 24 adequately nourished children within the same age range was also recruited from a well-baby clinic. These children did not receive the supplement nor placebo.
Intervention
The supplement comprised 5 mg elemental zinc daily (providing approximately 50% RDA) as zinc sulphate heptahydrate in 5 ml¯avoured syrup, while the placebo comprised the syrup only. Caretakers were blind to the children's group assignment. They were instructed to give the children the syrup daily. In order to minimize the risk of the children receiving improper dosage, seven daily doses of the supplement or the placebo were left at the children's homes weekly, when the seven bottles from the previous week were recovered. The supplementation period lasted for 12 weeks. In addition to the zinc supplement or placebo, all the undernourished children were provided with a multivitamin supplement (Tropivite vitamin drops; Federated Pharmaceutical Co Ltd, Kingston, Jamaica) (see Appendix). Food supplements were expected to be provided by the nutrition clinics.
Measurements
All interviews and measurements were carried out by members of the study team who were unaware of the children's group assignments. Anthropometric measurements were carried out on enrolment, at 6 and 12 weeks as well as 12 months after enrolment. This last measurement was carried out to determine whether there was a time lag in the growth response following the supplementation period. The children's weights were measured using a transportable infant beam balance scale, recumbent lengths were measured on a length board, and head circumferences were measured using a¯exible tape measure, all using recommended protocols (Lohman. et al, 1988) . These measurements were carried out by one of two team members who had achieved high levels of reliability in all the measurements with the trainer (both, intra-class correlations r .98±.99), and with each other (intra-class correlations r .87±.99) on at least 10 children in the same age range, prior to the start of the study. On enrolment, a hair sample (about 1 cm from the scalp) was taken from the occipital area of the head of each child using a stainless steel scissors. The hair zinc content was measured in duplicate by¯ame atomic absorption spectroscopy using standard techniques (Harrison et al, 1969) . Results obtained by multiple standard addition and those from interpolation of signals from each sample on a calibration curve were not different, as such the latter were routinely used. The recovery of zinc in spiked samples was between 95 and 100%. The inter-assay coef®cients of variation of three samples containing low, medium and high zinc were 2.86, 3.03 and 2.64%, respectively.
A questionnaire was administered to the primary caretaker of each child in order to determine social background data and the child's previous health history. Inter-interviewer reliabilities for the questionnaires were high (concordance 98±100% between the trainer and each of two interviewers with at least 10 caretakers with children of the same age range prior to the start of the study).
During the weekly visits to deliver the supplement or placebo, a history of the children's illnesses in the previous week was obtained from the caretakers. Any symptom which occurred during the previous week, and the days on which they were present, were recorded. Ten symptoms were speci®cally asked about: apathy, anorexia, fever, coughing, nasal discharge, diarrhoea (any loose or frequent stools identi®ed by the mother as`running belly'), vomiting, rapid or dif®cult breathing, pain or discharge from the ear, and skin conditions (infected or not). Other symptoms were recorded as miscellaneous. The mother's judgement was accepted for all symptoms and no attempt was made to reach a diagnosis. The category`rapid or dif®cult breathing' would have included lobar and bronchopneumonia, and asthma. This morbidity history instrument was previously used by this research group and signi®cant differences were detected between stunted and non-stunted children (Grantham-McGregor et al, 1993) . Before the study, the interviewers were trained to administer the morbidity questionnaire, and they achieved a minimum of 96% concordance with the trainer in 10 consecutive interviews. At the end of the supplementation period, caretakers were asked the number of times the children had been taken to the doctor (excluding nutrition clinic visits).
The adequately nourished children did not have the weekly morbidity questionnaires, nor the 12 month anthropometric measurements. They had all other measurements. They did not receive the zinc supplement, the placebo, nor the vitamin supplement.
Ethics
Children with prolonged or serious symptoms were referred to the health clinics, or seen by the TMRU physicians. All the children were offered free attention from TMRU physicians throughout the study. Caretakers were fully informed about the study, con®dentiality ensured and signed consent was required before each child was enrolled. The study received approval from the University of the West Indies Ethical Committee, the Ministry of Health, Jamaica, and the Stanford University Administrative Panel on Human Subjects in Medical Research.
Statistical analyses
Data were recorded directly onto code sheets, then entered onto the computer. Analyses were performed using the SPSS for Windows package (SPSS Inc., Chicago). Appropriate transformations were used to normalize the data when necessary (Velleman & Hoaglin, 1981) . Enrolment characteristics were compared using ANOVA. Where these were signi®cant, post-ANOVA contrasts were used to determine which groups differed. The effect of the supplement on growth was examined using multiple regression analyses. The basic approach was to estimate the ®nal status (length, height or head circumference) using as the independent variables, status on enrolment, age, gender and supplementation status (zinc supplementation or control) within the undernourished groups only. The time periods examined were: enrolment to 6 weeks, enrolment to 12 weeks, 6 weeks to 12 weeks, and enrolment to 12 months. The growth over the 12 week study period was also compared between nutritional groups (undernourished vs. adequately nourished). For this, the zinc supplemented and control undernourished groups were combined since analysis indicated that there were no signi®cant differences in growth between them. In order to examine the relationship between the initial length and weight and the ®nal status, within the undernourished and adequately nourished groups, interaction terms (nutritional group X initial size) were entered in regressions predicting size at 12 weeks. These interaction terms were signi®cant, therefore initial size was adjusted separately for the undernourished and adequately nourished groups by calculating the residuals of regressions of initial size estimating ®nal size within each nutritional group. These residuals were then used as the dependent variables in analyses with independent variables age, gender and nutritional group.
For the morbidity questionnaire, the number of episodes of each symptom and the mean duration were calculated for each subject. An episode was de®ned as having ended after 3 d without the symptom. The effect of supplementation on incidence was examined by analyses of covariance for each symptom with group as the between-subjects factor. The covariates were child's gender and age on enrolment, sanitation rating and crowding.
Results
Five children, all from the control group, were hospitalized during the study, four of these children stayed in hospital for more than one night. Because of special feeding procedures in hospital these four were subsequently excluded from the study. Data from these children are included in the description of enrolment sample characteristics, but not in the growth or morbidity analyses.
Sample characteristics on enrolment are presented in Table 1 . Both undernourished groups were very similar on enrolment. There were no signi®cant differences between these groups in the previous number of hospital admissions, nor in any of the caretaker, family background or socioeconomic status variables examined. The adequately nourished comparison group was signi®cantly different from the undernourished groups in that a greater percentage of the caretakers were biological mothers, more children had their fathers living at home, and their caretakers were better educated; fewer children had been admitted to hospital prior to the start of the study; they had a greater number of possessions in their households (a proxy for better socioeconomic status), and they lived in less crowded conditions.
Hair samples were taken from all but one child who was almost bald, who was from the zinc supplemented group. There were no signi®cant differences in the hair zinc content among the three groups (Table 1) .
Food supplements should have been provided to all the nutrition clinic attenders (zinc supplemented and placebo groups). Caretakers were asked each week during the 12 week supplementation period whether they currently had a supply of food supplements. They reported that they had The 84 bottles containing syrup (with supplement or placebo) which were delivered to each child, were collected from the caretakers one week later (99.7% from the supplementation group; 99.6% from the placebo group). The number of bottles which were returned empty was calculated as a percent of bottles delivered, to give an indication of compliance. The percentage of empty bottles returned was high (zinc supplemented: (median, range) 98.8, 69.1±100.0%; placebo:96.4, 72.6±100.0%) and was not signi®cantly different between the groups.
The mean length, weight and head circumference of each group are presented in Table 2 . Supplementation status did not contribute signi®cantly to the growth in length, weight or head circumference over any of the time periods examined. Results of the regressions which examined the growth of the undernourished and adequately nourished groups over the 12 week study period indicated that nutritional group contributed signi®cantly to the variance in change scores of length, weight and head circumference. The positive regression coef®cients indicated that the adequately nourished children were growing more rapidly over this period. The median and range of cumulative episodes, and duration of each symptom over the 12 weeks of the study are given in Table 3 , for the zinc supplemented and placebo controlled groups. No case of measles, tetanus or whooping cough occurred. Zinc supplementation had no signi®cant effect on the incidence of any symptom. Mean duration of the episodes was signi®-cantly shorter for skin rashes in the zinc supplemented group compared with the control group (F(1,23) 5.68, P`0.05), and longer for vomiting (F(1,21) 4.60, P`0.05) ( Table 3 ). The reported number of clinic visits was not signi®cantly different between the groups. However, the incidence of hospitalization was signi®cantly greater in the control group (®ve children were hospitalized) than in vthe supplemented group (no children were hospitalized) (Fisher's exact test, two-tailed, P 0.02). The children were admitted with gastroenteritis (3), pneumonia (1) and asthma (1). Zinc supplementation in Jamaican children JM Meeks Gardner et al
Discussion
The study design was that of a randomized, double-blind, placebo-controlled trial. There were no signi®cant differences between the zinc supplemented and the placebo groups on enrolment, indicating that the randomisation was effective. Good reliabilities were established for all measurements, and good compliance of the subjects' caretakers in giving the treatment was suggested by the high rate of returned empty bottles. No subjects were lost from the study. However, the ®ve control children who were hospitalized probably represented the most severe cases of illness, and excluding four of them may have reduced the likelihood of ®nding signi®cant differences between the groups in the other morbidity variables examined. It was necessary to exclude them since in some cases hospitalization may have included zinc supplements and the feeding regimes would have been markedly different from the situation at home. The one child who was in hospital overnight was not excluded.
Relatively few children had hair zinc concentrations below the cutoff for zinc de®ciency (`1.07 mmolag) (Gibson 1990) , 4 (13%) in the zinc supplemented group and 6 (19%) in the placebo group. This might suggest that zinc de®ciency in this sample of previously malnourished children was marginal. However, hair zinc content is not a valid measure of zinc status in cases of severe malnutrition as levels may be normal or even high (Gibson, 1990) .
There was a signi®cantly greater incidence of hospitalization among the control group, suggesting a greater severity of illness than among the zinc supplemented group. This suggests that providing zinc to undernourished children at the nutrition clinics may reduce the severity of the usual illnesses experienced, and reduce the numbers of children who require hospitalization.
It was assumed that on recruitment these undernourished children would be experiencing`catch-up growth', as such the sample size had a 80% power to detect a 500 g difference in weight gain between the zinc supplemented and placebo groups, at the 5% signi®cance level. Several previous studies have detected growth differences between zinc supplemented and control groups with similar or smaller sample sizes (Walravens et al, 1976 (Walravens et al, , 1983 (Walravens et al, , 1989 (Walravens et al, , 1992 Gibson et al, 1989; Castillo-Duran et al, 1987 Schlesinger et al, 1992; Nakamura et al, 1993; Shrivastava et al, 1993) , and this difference was detected within three months in some cases. However, we found no signi®cant effects of zinc supplementation on growth. All children were provided with vitamin supplements so it is unlikely that vitamins were limiting, although the supply of other minerals such as sulphur (Golden, 1994) may have been inadequate. It is also possible that there was insuf®cient energy and protein available to effect a growth response. The ®nding that the adequately nourished group was growing more rapidly than the undernourished groups, rather than the reverse which would be expected if the undernourished children were in`catch-up growth', supports this possibility. Food supplements were expected to be provided by the nutrition clinics as part of their routine care, but delivery was extremely irregular and caretakers had food supplements on average only 1 week during the 12 week supplementation period.
It is also possible that there was a time lag between the 12 week zinc supplementation period and a growth response. The children were measured 12 months after enrolment, or 9 months after the end of the supplementation period, but there were no signi®cant differences in growth over this time period. While it remains possible that a longer supplementation period may have been necessary to show effects of growth, other studies have detected improvements in growth over three months. However, at least two studies did not report a positive effect of zinc on growth over longer periods. In Guatemala, school aged children who received zinc for 25 weeks did not show signi®cant improvements in linear growth or weight gain compared with a control group (Cavan et al, 1993b) , and in a recent Mexican study of preschool children supplemented for 12 months, zinc supplements with or without iron had no signi®cant effect on growth (Rosado et al, 1997) . These studies and ours indicate that zinc supplementation in undernourished populations does not necessarily result in improved growth.
In the Mexican study mentioned above, zinc supplementation reduced the incidence of morbidity: the supplemented group had fewer episodes of disease. Our sample size was small for detecting differences in morbidity patterns. We found no signi®cant effects of the zinc supplementation on the number of episodes of illness and no consistent pattern of a positive effect of zinc on duration of illness. The zinc supplemented group had a shorter mean duration of skin rashes but longer duration of vomiting. These may represent chance ®ndings. However, diverse forms of skin lesions are a known sign of zinc de®ciency (CzajdkaNairns, 1996) and the reduced duration of skin rashes may have been a genuine response to zinc supplementation. On the other hand, high levels of zinc sulphate in adults can cause gastro-intestinal irritation and vomiting (CzajdkaNairns, 1996) , so it is possible that the zinc sulphate in the supplement may have contributed to the longer duration of vomiting compared with the control group. However, the amount provided was low (5 mg), and unlikely to have been responsible for an adverse effect in the children. We were unable to ®nd previous reports of increased vomiting as a result of zinc supplementation.
Some studies have indicated that the effects of zinc supplementation on morbidity tend to be more marked in boys (Ruel et al, 1995; Sazawal et al, 1997 ), but our sample was small for performing sub-sample analyses.
Our results contrast with other studies in which zinc supplementation resulted in reduced incidence or duration of diarrhoea or respiratory infections (Sazawal et al, 1995; but are very similar to reports of morbidity among stunted and non-stunted children in a previous Jamaican study (Grantham-McGregor et al, 1993) . The Jamaican population may be less exposed to these illnesses since both the zinc supplemented and the placebo groups showed fairly low rates of morbidity, and the low incidence of many symptoms would contribute to the dif®culty in detecting signi®cant differences between the groups. The improvement in the health status of Jamaican and Caribbean children over the last few decades has been documented (Sinha, 1988) and rates of morbidity tend to be lower than in other developing countries.
Conclusions
Zinc supplementation given to young, stunted Jamaican children resulted in fewer hospitalisations but did not result in improved growth. These ®ndings may have implications for the treatment of undernourished children. 
